OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $187,600 | -71.3% | 56,000 | -62.8% | 0.00% | – |
| Q2 2023 | $653,604 | +1081.6% | 150,600 | +920.9% | 0.00% | – |
| Q1 2023 | $55,316 | -48.1% | 14,751 | -51.2% | 0.00% | – |
| Q4 2022 | $106,613 | -78.4% | 30,202 | -87.7% | 0.00% | – |
| Q3 2022 | $494,000 | -3.3% | 245,593 | -7.7% | 0.00% | – |
| Q2 2022 | $511,000 | +79.9% | 266,133 | +203.4% | 0.00% | – |
| Q1 2022 | $284,000 | -77.4% | 87,723 | -74.0% | 0.00% | – |
| Q4 2021 | $1,258,000 | +47.8% | 336,758 | +103.9% | 0.00% | – |
| Q3 2021 | $851,000 | +172.8% | 165,194 | +179.2% | 0.00% | – |
| Q2 2021 | $312,000 | – | 59,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
| Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
| MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
| Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
| Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |